[1]
P. P. Shivgunde, S. R. Joshi, and A. D. Kodilkar, “The observational, cross-sectional study of drug utilization 90% and use of dipeptidyl peptidase-4 inhibitor in the patients with type 2 diabetes mellitus”, Int J Basic Clin Pharmacol, vol. 8, no. 11, pp. 2376–2382, Oct. 2019.